Chronic obstructive pulmonary disease in the adult population within the Middle East and North Africa region: rationale and design of the BREATHE study

被引:30
|
作者
El Hasnaoui, Abdelkader [1 ]
Rashid, Nauman [1 ]
Lahlou, Aicha [2 ]
Salhi, Hocine [3 ]
Doble, Adam [3 ]
Nejjari, Chakib [4 ]
机构
[1] GlaxoSmithKline, Dubai, U Arab Emirates
[2] MS Hlth, Rabat, Morocco
[3] Foxymed, Paris, France
[4] Univ Fez, Dept Epidemiol, Fes, Morocco
关键词
COPD; Middle East; North Africa; BREATHE study; Epidemiology; Prevalence; Smoking; COPD ASSESSMENT TEST; BURDEN; PREVALENCE; HEALTH; EPIDEMIOLOGY; PREVENTION; MANAGEMENT; SMOKING;
D O I
10.1016/S0954-6111(12)70010-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of the BREATHE study was to estimate the regional prevalence of chronic obstructive pulmonary disease (COPD) symptoms within the general population in the Middle East/North Africa (MENA) region and to document risk factors, disease characteristics and management using a standardised methodology. This was an observational population-based survey performed in ten countries in the Middle East and North Africa (Algeria, Egypt, Jordan, Lebanon, Morocco, Saudi Arabia, Syria, Tunisia, Turkey and United Arab Emirates), together with Pakistan. A general population sample of 10,000 subjects >= 40 years of age in each country or zone was generated from random telephone numbers. Structured interviews were proposed by telephone. A screening questionnaire was administered to each subject collecting information on respiratory symptoms and smoking habits. Subjects with chronic bronchitis or breathlessness and smoking >= 10 pack years fulfilled the epidemiological definition of COPD ("COPD" population). This population then completed a full disease questionnaire, the COPD Assessment Test (CAT) and a cost-of-disease questionnaire. A randomly selected sample was also assessed by spirometry. In all, 457,258 telephone numbers were generated and contact was established with 210,121 subjects, of whom 65,154 were eligible and 62,086 accepted to participate. The overall response rate was 74.2%. 2,187 (3.5%) subjects fulfilled the criteria for the "COPD" population. Evaluable spirometry data were obtained from 1,847 (14.2%) subjects to whom it was proposed.
引用
收藏
页码:S3 / S15
页数:13
相关论文
共 50 条
  • [31] Rationale and design of the Early Chronic Obstructive Pulmonary Disease (ECOPD) study in Guangdong, China: a prospective observational cohort study
    Wu, Fan
    Zhou, Yumin
    Deng, Zhishan
    Wen, Xiang
    Wang, Zihui
    Zheng, Youlan
    Tian, Heshen
    Yang, Huajing
    Huang, Peiyu
    Zhao, Ningning
    Sun, Ruiting
    Chen, Rongchang
    Ran, Pixin
    JOURNAL OF THORACIC DISEASE, 2021, 13 (12) : 6924 - +
  • [32] The Association Between Obesity And Chronic Obstructive Pulmonary Disease (COPD) In A Hospital In The North East
    Hanna, M.
    Ponce, F.
    Naranjo, M. B.
    Ghazarian, Z.
    Syed, Z.
    Sekhon, R.
    Pandya, T.
    Ismail, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [33] Mendelian randomization study of childhood asthma and chronic obstructive pulmonary disease in European and East Asian population
    Fan, Guo Zhen
    Chen, Ke Yang
    Liu, Xiao Meng
    Qu, Zheng Hai
    WORLD ALLERGY ORGANIZATION JOURNAL, 2024, 17 (09):
  • [34] Rationale and design of the PRSM study: Pulmonary rehabilitation or self management for chronic obstructive pulmonary disease (COPD), what is the best approach?
    Chang, Angela T.
    Haines, Terry
    Jackson, Claire
    Yang, Ian
    Nitz, Jennifer
    Choy, Nancy Low
    Vicenzino, Bill
    CONTEMPORARY CLINICAL TRIALS, 2008, 29 (05) : 796 - 800
  • [35] The Reconditioning Exercise and Chronic Obstructive Pulmonary Disease Trial II (REACT II): Rationale and study design for a clinical trial of physical activity among individuals with chronic obstructive pulmonary disease
    Foy, CG
    Wickley, KL
    Adair, NN
    Lang, W
    Miller, ME
    Rejeski, WJ
    Woodard, CM
    Berry, MJ
    CONTEMPORARY CLINICAL TRIALS, 2006, 27 (02) : 135 - 146
  • [36] TRANSFERABILITY OF DISEASE-RELATED COSTS OF CHRONIC IMMUNE-MEDIATED DISEASES WITHIN COUNTRIES OF THE MIDDLE EAST NORTH AFRICA REGION: THE CASE OF MULTIPLE SCLEROSIS
    Mhanna, L.
    Gulacsi, L.
    Pentek, M.
    Zrubka, Z.
    VALUE IN HEALTH, 2022, 25 (01) : S176 - S176
  • [37] Cardiovascular disease burden in the North Africa and Middle East region: an analysis of the global burden of disease study 1990-2021
    Soleimani, Hamidreza
    Nasrollahizadeh, Ali
    Nasrollahizadeh, Amir
    Razeghian, Iman
    Molaei, Mohammad Mahdi
    Hakim, Diaa
    Nasir, Khurram
    Al-Kindi, Sadeer
    Hosseini, Kaveh
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):
  • [38] Awareness of Chronic Obstructive Pulmonary Disease and Its Risk Factors Among the Adult Population of the Qassim Region, Saudi Arabia
    Almuzaini, Ahmed S.
    Algeffari, Mutab
    Alsohaibani, Asma
    Almutlaq, Latifah Y.
    Alwehaibi, Raghad
    Almuzaini, Reema A.
    Mahmood, Syed E.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [39] Knowledge and attitude of primary care physicians towards obstructive sleep apnea in the Middle East and North Africa region
    Hassan Al-Khafaji
    Izci Balserak Bilgay
    Hani Tamim
    Reem Hoteit
    Georges Assaf
    Sleep and Breathing, 2021, 25 : 579 - 585
  • [40] Knowledge and attitude of primary care physicians towards obstructive sleep apnea in the Middle East and North Africa region
    Al-Khafaji, Hassan
    Bilgay, Izci Balserak
    Tamim, Hani
    Hoteit, Reem
    Assaf, Georges
    SLEEP AND BREATHING, 2021, 25 (02) : 579 - 585